V

Verrica Pharmaceuticals

D
VRCA
USD
0.09
(4.8649%)
Market Closed
13,639.00
Volume
-1.435
EPS
-
Div Yield
-1.026455
P/E
82,776,992.82
Market Cap
Today
4.8649%
1 Week
0.000%
1 Month
-34.237%
6 Months
-58.898%
12 Months
-51.861%
Year To Date
-73.533%
All Time
0%

Title:
Verrica Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Do you need help or have a question?